{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:31:08Z","timestamp":1784953868649,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.neuropharm.2006.02.008","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T12:05:47Z","timestamp":1145534747000},"page":"1048-1058","source":"Crossref","is-referenced-by-count":33,"title":["Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior"],"prefix":"10.1016","volume":"50","author":[{"given":"Peter","family":"Salchner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone B.","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrin","family":"Sinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Wigger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Landgraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Singewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2006.02.008_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2005.03.025","article-title":"Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs","volume":"133","author":"Abrams","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S0100-879X2001000200001","article-title":"The brain decade in debate: II. Panic or anxiety? From animal models to a neurobiological basis","volume":"34","author":"Andreatini","year":"2001","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0163-7258(00)00083-8","article-title":"The psychobiology of anxiolytic drug. Part 2: Pharmacological treatments of anxiety","volume":"88","author":"Argyropoulos","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib4","series-title":"Neuropsychopharmacology: the 5th Generation of Progress","first-page":"883","article-title":"Animal models and endophenotypes of anxiety and stress disorders","author":"Bakshi","year":"2002"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0079-6123(08)62133-0","article-title":"Neurobiological correlates of defensive behaviors","volume":"122","author":"Bakshi","year":"2000","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0887-6185(00)00042-6","article-title":"Neurological bases for balance-anxiety links","volume":"15","author":"Balaban","year":"2001","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neubiorev.2004.06.013","article-title":"Anxiety and panic: from human studies to animal research and back","volume":"29","author":"Battaglia","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1523\/JNEUROSCI.15-01-00709.1995","article-title":"Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment","volume":"15","author":"Beck","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0361-9230(96)00332-2","article-title":"Central c-fos expression following 20kHz\/ultrasound induced defence behaviour in the rat","volume":"42","author":"Beckett","year":"1997","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1096-9861(19981130)401:4<429::AID-CNE1>3.0.CO;2-3","article-title":"Parallel circuits for emotional coping behaviour: new pieces in the puzzle","volume":"401","author":"Bernard","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0149-7634(96)00062-0","article-title":"Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries","volume":"21","author":"Blanchard","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0149-7634(01)00009-4","article-title":"Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic","volume":"25","author":"Blanchard","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0006-3223(02)01355-0","article-title":"rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest","volume":"52","author":"Boshuisen","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib14","first-page":"79","article-title":"Animal models of anxiety: are they suitable for predicting drug action in humans?","volume":"49","author":"Bourin","year":"1997","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0306-4522(96)00632-X","article-title":"Elicitation and reduction of fear: behavioural and neuroendocrine indices and brain induction of the immediate-early gene c-fos","volume":"78","author":"Campeau","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(97)00141-X","article-title":"Severe reduction of rat defensive behavior to a predator by discrete hypothalamic chemical lesions","volume":"44","author":"Canteras","year":"1997","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/cne.903480309","article-title":"Spatially and temporally differentiated patterns of c-fos expression in brainstem catecholaminergic cell groups induced by cardiovascular challenges in the rat","volume":"348","author":"Chan","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archpsyc.1984.01790190025003","article-title":"Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder","volume":"41","author":"Charney","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0447.1992.tb03266.x","article-title":"Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients","volume":"86","author":"Charney","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/107385849800400111","article-title":"The neurobiological basis of anxiety and fear: Circuits, mechanisms, and neurochemical interactions (part I)","volume":"4","author":"Charney","year":"1998","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib21","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0006-3223(98)00300-X","article-title":"Brain circuits in panic disorder","volume":"44","author":"Coplan","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib22","series-title":"Psychopharmacology","first-page":"1325","article-title":"Environmental factors in the etiology of anxiety","author":"Craig","year":"1995"},{"issue":"Suppl. 4","key":"10.1016\/j.neuropharm.2006.02.008_bib23","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/00004850-199804004-00005","article-title":"Review of current treatment in panic disorder","volume":"13","author":"den Boer","year":"1998","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(83)90076-4","article-title":"Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors","volume":"2","author":"Dorow","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib25","series-title":"Diagnostic and Statistical Manual of Mental Disorders 4th edition","author":"DSM-IV","year":"1994"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(95)01486-1","article-title":"Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety","volume":"713","author":"Duncan","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0006-8993(99)01931-9","article-title":"Differential forebrain c-fos mRNA induction by ether inhalation and novelty: evidence for distinctive stress pathways","volume":"845","author":"Emmert","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2004.10.044","article-title":"Neural segregation of Fos-protein distribution in the brain following freezing and escape behaviors induced by injections of either glutamate or NMDA into the dorsal periaqueductal gray of rats","volume":"1031","author":"Ferreira-Netto","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib29","first-page":"198","article-title":"The anxiogenic action of FG 7142 in the social interaction test is reversed by chlordiazepoxide and Ro 15-1788 but not by CGS 8216","volume":"271","author":"File","year":"1984","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2006.02.008_bib30","first-page":"4","article-title":"Toward an integrated neurobiology of panic disorder","volume":"58","author":"Goddard","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","article-title":"Neuroanatomical hypothesis of panic disorder, revised. Am","volume":"157","author":"Gorman","year":"2000","journal-title":"J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00213-002-1112-4","article-title":"On serotonin and experimental anxiety","volume":"163","author":"Graeff","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib33","series-title":"Biological Psychiatry","first-page":"1","article-title":"Animal models of anxiety","author":"Graeff","year":"2002"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib34","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/0028-3908(95)00121-2","article-title":"Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam","volume":"34","author":"Griebel","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-0173(01)00082-0","article-title":"Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus","volume":"38","author":"Harro","year":"2001","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0091-3057(98)00255-X","article-title":"Intravenous cocaine precipitates panic-like flight responses and lasting hyperdefensiveness in laboratory rats","volume":"63","author":"Hebert","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(96)00471-2","article-title":"The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze","volume":"312","author":"Hinks","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2826.2002.00775.x","article-title":"Anatomical markers of activity in neuroendocrine systems: are we all \u2019fos-ed out\u2019?","volume":"14","author":"Hoffman","year":"2002","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-002-1095-1","article-title":"Anxiogenic, not psychotogenic, properties of the partial inverse benzodiazepine receptor agonist FG 7142 in man","volume":"162","author":"Horowski","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0165-1781(95)02673-K","article-title":"Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity","volume":"57","author":"Jenck","year":"1995","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib41","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00213-002-1029-y","article-title":"Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents","volume":"161","author":"Jones","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuroimage.2004.06.012","article-title":"High trait anxiety and hyporeactivity to stress of the dorsomedial prefrontal cortex: a combined phMRI and Fos study in rats","volume":"23","author":"Kalisch","year":"2004","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s11920-003-0055-8","article-title":"Neurocircuitry of anxiety disorders","volume":"5","author":"Kent","year":"2003","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0166-4328(98)00062-X","article-title":"Escape-related behaviours in an unstable elevated and exposed environment. I. A new behavioural model of extreme anxiety","volume":"98","author":"King","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0166-4328(98)00061-8","article-title":"Escape-related behaviours in an unstable, elevated and exposed environment. II. Long-term sensitization after repetitive electrical stimulation of the rodent midbrain defence system","volume":"98","author":"King","year":"1999","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0197-0186(98)00023-0","article-title":"c-Fos as a transcription factor: a stressful (re)view from a functional map","volume":"33","author":"Kovacs","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib48","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00702-003-0023-9","article-title":"Distribution of anxiogenic-induced c-Fos in the forebrain regions of developing rats","volume":"110","author":"Kurumaji","year":"2003","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1020258104318","article-title":"High vs. low anxiety-related behavior rats: an animal model of extremes in trait anxiety","volume":"32","author":"Landgraf","year":"2002","journal-title":"Behav Genet."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/1025389031000104193","article-title":"Born to be anxious: neuroendocrine and genetic correlates of trait anxiety in HAB rats","volume":"6","author":"Landgraf","year":"2003","journal-title":"Stress"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2826.1999.00342.x","article-title":"Hyper-reactive hypothalamo-pituitary-adrenocortical axis in rats bred for high anxiety-related behaviour","volume":"11","author":"Landgraf","year":"1999","journal-title":"J. Neuroendocrinol"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0893-133X(98)00042-6","article-title":"Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior","volume":"19","author":"Liebsch","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0166-4328(97)00198-8","article-title":"Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour","volume":"94","author":"Liebsch","year":"1998","journal-title":"Behav Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib54","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/107385840000600113","article-title":"Panic disorder\u2014A malfunction of multiple transmitter control systems within the midbrain periaqueductal gray matter?","volume":"6","author":"Lovick","year":"2000","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib55","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1523\/JNEUROSCI.0187-04.2004","article-title":"Neural correlates of cat odor-induced anxiety in rats: region-specific effects of the benzodiazepine midazolam","volume":"24","author":"McGregor","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0006-3223(96)00407-6","article-title":"Effect of central and peripheral administrations of cholecystokinin-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat","volume":"42","author":"Mongeau","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002130050299","article-title":"Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats","volume":"131","author":"Mongeau","year":"1997","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib59","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1523\/JNEUROSCI.23-09-03855.2003","article-title":"Neural correlates of competing fear behaviors evoked by an innately aversive stimulus","volume":"23","author":"Mongeau","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.ne.14.030191.002225","article-title":"Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun","volume":"14","author":"Morgan","year":"1991","journal-title":"Annu. Rev. Neurosci."},{"issue":"Suppl. 5","key":"10.1016\/j.neuropharm.2006.02.008_bib61","first-page":"13","article-title":"High-potency benzodiazepines: recent clinical results","volume":"65","author":"Moroz","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/cne.903490104","article-title":"Directionally specific changes in arterial pressure induce differential patterns of fos expression in discrete areas of the rat brainstem: a double-labeling study for Fos and catecholamines","volume":"349","author":"Murphy","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib63","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0006-8993(99)02334-3","article-title":"Strain differences to the effects of aversive frequency ultrasound on behaviour and brain topography of c-fos expression in the rat","volume":"854","author":"Neophytou","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib64","first-page":"683","article-title":"Characterization of rat exploratory behavior using the exploration box test","volume":"19","author":"Otter","year":"1997","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib65","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0163-7258(92)90014-Q","article-title":"The neuroanatomical basis of anxiety","volume":"55","author":"Pratt","year":"1992","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-4328(94)90033-7","article-title":"Cardiovascular effects of the benzodiazepine receptor partial inverse agonist FG 7142 in rats","volume":"62","author":"Quigley","year":"1994","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0006-8993(86)90371-9","article-title":"Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies","volume":"371","author":"Rasmussen","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib69","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0028-3908(02)00329-5","article-title":"Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment","volume":"43","author":"Salchner","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2003.07.002","article-title":"Decreased social interaction in aged rats may not reflect changes in anxiety-related behaviour","volume":"151","author":"Salchner","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0166-4328(02)00135-3","article-title":"Reliability of high and low anxiety-related behaviour: influence of laboratory environment and multifactorial analysis","volume":"136","author":"Salome","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib72","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.biopsych.2003.10.021","article-title":"Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats","volume":"55","author":"Salome","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib73","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1176\/ajp.151.8.1220","article-title":"Alprazolam blockade of CO2-provoked panic in patients with panic disorder","volume":"151","author":"Sanderson","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0163-7258(00)00082-6","article-title":"The psychobiology of anxiolytic drugs. Part 1: Basic neurobiology","volume":"88","author":"Sandford","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib75","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0149-7634(01)00060-4","article-title":"Modeling panic attacks","volume":"25","author":"Schenberg","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib76","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130100859","article-title":"Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders","volume":"157","author":"Shekhar","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0166-4328(93)90028-O","article-title":"Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze","volume":"56","author":"Silveira","year":"1993","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib78","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00001756-199805110-00019","article-title":"Seizures in rats treated with kainic acid induce Fos-like immunoreactivity in locus coeruleus","volume":"9","author":"Silveira","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib79","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-4328(01)00233-9","article-title":"Differential expression of Fos protein in the rat brain induced by performance of avoidance or escape in the elevated T-maze","volume":"126","author":"Silveira","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib80","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-3223(02)01574-3","article-title":"Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs","volume":"53","author":"Singewald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib81","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0306-4522(00)00177-9","article-title":"Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry","volume":"98","author":"Singewald","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib82","first-page":"5","article-title":"The role of high-potency benzodiazepines in the treatment of panic disorder. Prim care companion","volume":"7","author":"Susman","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib83","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000071311","article-title":"Effects of treadmill running on brain activation and the corticotropin-releasing hormone system","volume":"77","author":"Timofeeva","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2006.02.008_bib84","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00004647-199607000-00025","article-title":"Exercise-induced changes in local cerebral glucose utilization in the rat","volume":"16","author":"Vissing","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib85","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1749-6632.1998.tb10707.x","article-title":"Galanin: a significant role in depression?","volume":"863","author":"Weiss","year":"1998","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2006.02.008_bib86","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.97.1.325","article-title":"Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone","volume":"97","author":"Wong","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T04:31:53Z","timestamp":1555561913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390806000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":85,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0028390806000347"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2006.02.008","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}